Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4936 AL 4950

Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2

Haure-Mirande JV, Audrain M, Ehrlich ME, Gandy S.

Mol Neurodegener. 2022 Aug 24;17(1):55. doi: 10.1186/s13024-022-00552-w.

Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition

Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M, Khanna S, Tiwari P, Parvez S, Iqubal A, Haque SE, Khan MA.

Inflammation. 2023 Feb;46(1):56-87. doi: 10.1007/s10753-022-01730-0. Epub 2022 Aug 25.

Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes

Dai R, Sun Y, Su R, Gao H.

Biomed Pharmacother. 2022 Oct;154:113576. doi: 10.1016/j.biopha.2022.113576. Epub 2022 Aug 22.

In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease

Schreiner TG, Creangă-Murariu I, Tamba BI, Lucanu N, Popescu BO.

Biomolecules. 2022 Aug 18;12(8):1136. doi: 10.3390/biom12081136.

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders

Assogna M, Di Lorenzo F, Martorana A, Koch G.

Biomolecules. 2022 Aug 22;12(8):1161. doi: 10.3390/biom12081161.

Exercise to Improve Postural Stability in Older Adults with Alzheimer's Disease: A Systematic Review of Randomized Control Trials

Adzhar MA, Manlapaz D, Singh DKA, Mesbah N.

Int J Environ Res Public Health. 2022 Aug 19;19(16):10350. doi: 10.3390/ijerph191610350.

Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration

Passarella D, Ciampi S, Di Liberto V, Zuccarini M, Ronci M, Medoro A, Foderà E, Frinchi M, Mignogna D, Russo C, Porcile C.

Int J Mol Sci. 2022 Aug 10;23(16):8921. doi: 10.3390/ijms23168921.

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease

Sun E, Motolani A, Campos L, Lu T.

Int J Mol Sci. 2022 Aug 11;23(16):8972. doi: 10.3390/ijms23168972.

Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment

Barczuk J, Siwecka N, Lusa W, Rozpędek-Kamińska W, Kucharska E, Majsterek I.

Int J Mol Sci. 2022 Aug 11;23(16):8979. doi: 10.3390/ijms23168979.

Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer's Disease

Pluta R, Januszewski S, Jabłoński M.

Int J Mol Sci. 2022 Aug 16;23(16):9174. doi: 10.3390/ijms23169174.

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach

Morató X, Pytel V, Jofresa S, Ruiz A, Boada M.

Int J Mol Sci. 2022 Aug 18;23(16):9305. doi: 10.3390/ijms23169305.

HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis

Borràs C, Mercer A, Sirisi S, Alcolea D, Escolà-Gil JC, Blanco-Vaca F, Tondo M.

Int J Mol Sci. 2022 Aug 19;23(16):9356. doi: 10.3390/ijms23169356.

Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer's Disease?

Di Natale G, Sabatino G, Sciacca MFM, Tosto R, Milardi D, Pappalardo G.

Molecules. 2022 Aug 9;27(16):5066. doi: 10.3390/molecules27165066.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias